These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. FDA, OSHA, and EPA regulation of the recombinant DNA technology. Korwek EL J Parenter Sci Technol; 1982; 36(6):251-5. PubMed ID: 7161657 [No Abstract] [Full Text] [Related]
4. Use of 'secondary mechanism' in the regulation of carcinogens; a chronology. Scheuplein RJ Cancer Lett; 1995 Jun; 93(1):103-12. PubMed ID: 7600537 [TBL] [Abstract][Full Text] [Related]
6. Biotechnology: can a new technology survive? Withers WW; Kenworthy PG St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845 [No Abstract] [Full Text] [Related]
8. Why the toxic substances control act needs an overhaul, and how to strengthen oversight of chemicals in the interim. Vogel SA; Roberts JA Health Aff (Millwood); 2011 May; 30(5):898-905. PubMed ID: 21555473 [TBL] [Abstract][Full Text] [Related]
9. EPA focuses on off-site consequences but overlap exists with process safety. Dennison M Occup Health Saf; 1994 Dec; 63(12):20-5. PubMed ID: 15655982 [No Abstract] [Full Text] [Related]
10. Databases applicable to quantitative hazard/risk assessment--towards a predictive systems toxicology. Waters M; Jackson M Toxicol Appl Pharmacol; 2008 Nov; 233(1):34-44. PubMed ID: 18675838 [TBL] [Abstract][Full Text] [Related]
11. Safety and health compliance for hazmat. The "HAZWOPER" (Worker Protection Standards for Hazardous Waste Operations and Emergency Response) standard. Golden JM JEMS; 1991 Oct; 16(10):28-31, 33. PubMed ID: 10116021 [TBL] [Abstract][Full Text] [Related]
12. Impact of the Delaney Clause in the EPA. Fenner-Crisp PA Exp Toxicol Pathol; 1996 Feb; 48(2-3):199-200. PubMed ID: 8672877 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride). Roberts SM; Jordan KE; Warren DA; Britt JK; James RC Regul Toxicol Pharmacol; 2002 Feb; 35(1):44-55. PubMed ID: 11846635 [TBL] [Abstract][Full Text] [Related]
14. Update of potency factors for asbestos-related lung cancer and mesothelioma. Berman DW; Crump KS Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157 [TBL] [Abstract][Full Text] [Related]
15. U.S. regulatory aspects of standardization for nanotechnologies. Marrapese M; Wall G Stand News; 2005 Jul; 33(7):40-3. PubMed ID: 16237874 [No Abstract] [Full Text] [Related]
17. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling. Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223 [TBL] [Abstract][Full Text] [Related]
18. Carcinogen risk assessment in the U.S. Environmental Protection Agency. Albert RE Crit Rev Toxicol; 1994; 24(1):75-85. PubMed ID: 8172652 [TBL] [Abstract][Full Text] [Related]
19. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB. Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433 [TBL] [Abstract][Full Text] [Related]
20. A regulatory relic: After 60 years of research on cancer risk, the Delaney Clause continues to keep us in the past. Krishan M; Navarro L; Beck B; Carvajal R; Dourson M Toxicol Appl Pharmacol; 2021 Dec; 433():115779. PubMed ID: 34737146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]